Hollencrest Capital Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-80,355
| Closed | -$256K | – | 349 |
|
|
2022
Q2 | $256K | Sell |
80,355
-2,000
| -2% | -$7.79K | 0.03% | 235 |
|
|
2022
Q1 | $352K | Hold |
82,355
| – | – | 0.03% | 233 |
|
|
2021
Q4 | $383K | Buy |
82,355
+40,000
| +94% | +$167K | 0.03% | 238 |
|
|
2021
Q3 | $169K | Hold |
42,355
| – | – | 0.02% | 339 |
|
|
2021
Q2 | $181K | Buy |
42,355
+3,355
| +9% | +$14.4K | 0.02% | 342 |
|
|
2021
Q1 | $165K | Sell |
39,000
-10,000
| -20% | -$55.1K | 0.02% | 333 |
|
|
2020
Q4 | $190K | Buy |
49,000
+10,000
| +26% | +$42.7K | 0.02% | 306 |
|
|
2020
Q3 | $157K | Buy |
39,000
+11,000
| +39% | +$45.6K | 0.02% | 300 |
|
|
2020
Q2 | $119K | Buy |
28,000
+18,000
| +180% | +$110K | 0.02% | 273 |
|
|
2020
Q1 | $42K | Hold |
10,000
| – | – | 0.01% | 297 |
|
|
2019
Q4 | $39K | Hold |
10,000
| – | – | ﹤0.01% | 335 |
|
|
2019
Q3 | $88K | Hold |
10,000
| – | – | 0.01% | 308 |
|
|
2019
Q2 | $93K | Hold |
10,000
| – | – | 0.01% | 306 |
|
|
2019
Q1 | $64K | Hold |
10,000
| – | – | 0.01% | 315 |
|
|
2018
Q4 | $94K | Sell |
10,000
-10,000
| -50% | -$150K | 0.01% | 290 |
|
|
2018
Q3 | $265K | Buy |
20,000
+9,000
| +82% | +$235K | 0.02% | 300 |
|
|
2018
Q2 | $321K | Buy |
+11,000
| New | +$340K | 0.04% | 201 |
|
|
2017
Q4 | – | Sell |
-22,092
| Closed | -$768K | – | 351 |
|
|
2017
Q3 | $768K | Hold |
22,092
| – | – | 0.11% | 126 |
|
|
2017
Q2 | $658K | Hold |
22,092
| – | – | 0.1% | 131 |
|
|
2017
Q1 | $659K | Hold |
22,092
| – | – | 0.1% | 143 |
|
|
2016
Q4 | $387K | Hold |
22,092
| – | – | 0.06% | 192 |
|
|
2016
Q3 | $526K | Hold |
22,092
| – | – | 0.08% | 175 |
|
|
2016
Q2 | $353K | Hold |
22,092
| – | – | 0.05% | 241 |
|
|
2016
Q1 | $462K | Hold |
22,092
| – | – | 0.08% | 189 |
|
|
2015
Q4 | $596K | Sell |
22,092
-22,908
| -51% | -$625K | 0.11% | 166 |
|
|
2015
Q3 | $1.25M | Hold |
45,000
| – | – | 0.22% | 85 |
|
|
2015
Q2 | $1.1M | Hold |
45,000
| – | – | 0.16% | 111 |
|
|
2015
Q1 | $824K | Buy |
+45,000
| New | +$912K | 0.11% | 131 |
|
Hollencrest Capital Management's LJPC Position: Q3 2022 in Review
Hollencrest Capital Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2022, closing a stake of 80,355 shares — an estimated $256K sold.
Hollencrest Capital Management first reported a position in LJPC in Q1 2015 and held it in 28 quarters. The position peaked at $1.25M in Q3 2015. 0 funds tracked by Wall St. Rank hold LJPC as of Q3 2022.
- Hollencrest Capital Management reported no remaining La Jolla Pharmaceutical Company position as of Q3 2022 after selling out during the quarter.
- Hollencrest Capital Management sold 80,355 La Jolla Pharmaceutical Company shares in Q3 2022, an estimated $256K.
- Hollencrest Capital Management first reported a position in La Jolla Pharmaceutical Company in Q1 2015 and held it in 28 quarters.
- Hollencrest Capital Management's La Jolla Pharmaceutical Company position peaked at $1.25M in Q3 2015.
- 0 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2022.
Based on Hollencrest Capital Management's 13F filing for Q3 2022, filed 28 Oct 2022.